Core One's Akome Reveals Groundbreaking Positive Results from its Second Round of Stage 1 Animal Model Studies for Bio-Compounds Targeting Alzheimer's and Parkinson's Disease Seite 1

05.08.2023 - VANCOUVER, BC / ACCESSWIRE / August 4, 2023 / Core One Labs Inc. (CSE:COOL) (OTCQB:CLABF) (Frankfurt:LD6, WKN:A3CSSU), (the 'Company' or 'Core One') is delighted to announce the receipt of additional positive results from its second round ('Round ... Seite 1

Related Keywords

United States ,Spain ,Vancouver ,British Columbia ,Canada , ,Treaty Office ,Akome Biotechnologies Inc ,Core One Labs Inc ,Company Or Core ,Core One Labs ,Universitat De Barcelona ,Core One ,Akome Biotechnologies ,Ischemic Stroke ,Bio Compoundsa E ,United States Patent ,